SPEX stock forecast
Our latest prediction for Spherix, Inc.'s stock price was made on the Nov. 19, 2018 when the stock price was at 0.90$.
In the short term (2weeks), SPEX's stock price should outperform the market by 4.13%. During that period the price should oscillate between -6.98% and +15.77%.
In the medium term (3months), SPEX's stock price should outperform the market by 8.11%. During that period the price should oscillate between -17.01% and +50.51%.Get email alerts
Create a solid portfolio with SPEX
About Spherix, Inc.
Spherix, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.64$ per share.
The book value per share is 0.99$
Three months stock forecastNov. 19, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|